Cargando…

DNA Nanotechnology for Cancer Therapy

DNA nanotechnology is an emerging and exciting field, and represents a forefront frontier for the biomedical field. The specificity of the interactions between complementary base pairs makes DNA an incredible building material for programmable and very versatile two- and three-dimensional nanostruct...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vinit, Palazzolo, Stefano, Bayda, Samer, Corona, Giuseppe, Toffoli, Giuseppe, Rizzolio, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805665/
https://www.ncbi.nlm.nih.gov/pubmed/27022418
http://dx.doi.org/10.7150/thno.14203
_version_ 1782423181864206336
author Kumar, Vinit
Palazzolo, Stefano
Bayda, Samer
Corona, Giuseppe
Toffoli, Giuseppe
Rizzolio, Flavio
author_facet Kumar, Vinit
Palazzolo, Stefano
Bayda, Samer
Corona, Giuseppe
Toffoli, Giuseppe
Rizzolio, Flavio
author_sort Kumar, Vinit
collection PubMed
description DNA nanotechnology is an emerging and exciting field, and represents a forefront frontier for the biomedical field. The specificity of the interactions between complementary base pairs makes DNA an incredible building material for programmable and very versatile two- and three-dimensional nanostructures called DNA origami. Here, we analyze the DNA origami and DNA-based nanostructures as a drug delivery system. Besides their physical-chemical nature, we dissect the critical factors such as stability, loading capability, release and immunocompatibility, which mainly limit in vivo applications. Special attention was dedicated to highlighting the boundaries to be overcome to bring DNA nanostructures closer to the bedside of patients.
format Online
Article
Text
id pubmed-4805665
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-48056652016-03-28 DNA Nanotechnology for Cancer Therapy Kumar, Vinit Palazzolo, Stefano Bayda, Samer Corona, Giuseppe Toffoli, Giuseppe Rizzolio, Flavio Theranostics Review DNA nanotechnology is an emerging and exciting field, and represents a forefront frontier for the biomedical field. The specificity of the interactions between complementary base pairs makes DNA an incredible building material for programmable and very versatile two- and three-dimensional nanostructures called DNA origami. Here, we analyze the DNA origami and DNA-based nanostructures as a drug delivery system. Besides their physical-chemical nature, we dissect the critical factors such as stability, loading capability, release and immunocompatibility, which mainly limit in vivo applications. Special attention was dedicated to highlighting the boundaries to be overcome to bring DNA nanostructures closer to the bedside of patients. Ivyspring International Publisher 2016-03-20 /pmc/articles/PMC4805665/ /pubmed/27022418 http://dx.doi.org/10.7150/thno.14203 Text en © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions.
spellingShingle Review
Kumar, Vinit
Palazzolo, Stefano
Bayda, Samer
Corona, Giuseppe
Toffoli, Giuseppe
Rizzolio, Flavio
DNA Nanotechnology for Cancer Therapy
title DNA Nanotechnology for Cancer Therapy
title_full DNA Nanotechnology for Cancer Therapy
title_fullStr DNA Nanotechnology for Cancer Therapy
title_full_unstemmed DNA Nanotechnology for Cancer Therapy
title_short DNA Nanotechnology for Cancer Therapy
title_sort dna nanotechnology for cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805665/
https://www.ncbi.nlm.nih.gov/pubmed/27022418
http://dx.doi.org/10.7150/thno.14203
work_keys_str_mv AT kumarvinit dnananotechnologyforcancertherapy
AT palazzolostefano dnananotechnologyforcancertherapy
AT baydasamer dnananotechnologyforcancertherapy
AT coronagiuseppe dnananotechnologyforcancertherapy
AT toffoligiuseppe dnananotechnologyforcancertherapy
AT rizzolioflavio dnananotechnologyforcancertherapy